查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
放射组学市场——全球行业规模、份额、趋势、竞争、机遇和预测：按形态、图像类型、技术、应用、地区和竞争对手分类（2018-2028 年）
市场调查报告书
商品编码
1244135

放射组学市场——全球行业规模、份额、趋势、竞争、机遇和预测：按形态、图像类型、技术、应用、地区和竞争对手分类（2018-2028 年）

Radiomics Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Modality, By Image Type, By Technology, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在 2018-2028 年的预测期内，全球放射组学市场预计将以惊人的速度增长。

这可能是由于癌症等各种慢性病的患病率越来越高，需要准确的诊断和治疗。 根据世界癌症观察站的数据，2020 年报告的新癌症病例总数约为 19,292,789 例。 其中，2020 年将报告 10,065,305 例男性癌症新病例和 9,227,484 例女性癌症新病例。 对改进疾病诊断、预后和临床决策支持的需求不断增长，预计将为全球放射组学市场的增长带来新的前景。

医疗行业数字化和人工智能应用的推进

在过去的几十年里，医学领域已稳步将常规临床程序中生成的信息数字化。 随着医疗记录变得更加数字化，用于分析它们的软件也在不断发展并变得更加复杂。 与此同时，人工智能（AI）的研究也取得了进展，其技术和软件工具已经跳出了计算机科学系，现在被应用到各个领域。 因此，医疗保健行业近年来人工智能应用程序的使用显着增加。 这些应用程序旨在支持临床决策并简化医生每天必须执行的重复性任务。

放射组学在现代数学分析的帮助下增强了医生可用的数据。 从根本上说，放射组学的概念在肿瘤学领域最为普遍，它基于这样一种假设，即某些特定疾病的信息存在于人眼无法察觉的生物医学图像中。

在医学图像的放射组学分析中，利用从正电子 CT、MRI 和 PET 获得的图像信息的附加值，跨模态进行综合分析，而不是单独评估每个模态。多种模态可用，因为有可能 因此，人工智能与医疗保健行业的整合将在未来推动全球放射组学市场的发展。

在医学诊断中越来越依赖放射学

医学诊断成像不仅有助于成人的诊断，也有助于儿童的诊断，并开闢了新的治疗方法。

根据国家卫生服务局 (NHS) 的一份报告，2018 年 10 月至 2019 年 9 月期间，英格兰进行了大约 4520 万次影像学检查。 其中，2019 年 9 月仅进行了 358 万次影像学研究。

这种升级可归因于医生和患者需求的增加、技术的改进以及人口经济状况的改善。 计算机断层扫描和 CT 扫描在过去十年中增长了约 8%。 一项研究发现，从 2001 年到 2010 年，因呼吸系统疾病而进行急诊科 CT 扫描的比率增加了四倍。

技术进步导致越来越多的医生要求进行 CT 扫描和 MRI 检查，以了解可以通过更简单的影像学检查的情况。 与普通 X 光片相比，CT 扫描可以更好地了解病情。 例如，用于确认和随访肺栓塞的首选成像技术是 CT 肺动脉造影。 主要原因是它的高速和高分辨率。 由于 CT 扫描具有高度敏感性、特异性和高度可见性，因此它们可以检测到胸部 X 光检查可能会漏掉的小空腔。 它还可以检测胸部 X 光检查可能漏掉的小病灶。 此外，一些区域，如肺底部和肺舌，可以更好地观察。 因此，在医学诊断中越来越依赖放射学为全球放射组学市场提供了有利可图的增长机会。

老年人口增长及相关疾病

随着年龄的增长，我们患疾病的风险也会增加。 根据美国疾病控制和预防中心 (CDC) 的数据，大约 80% 的美国老年人至少患有一种慢性病。 此外，美国医学协会 (AMA) 估计，到 2030 年，大约 60% 的 65 岁及以上的人将患有多种慢性病。 因此，世界上日益老龄化的人口将增加对更好的医疗保健设施、现代疗法和药物的需求。

此外，由于世界慢性病的增加，对最新诊断和治疗方法的需求也在增加。 放射学技术和医学成像，例如磁共振成像 (MRI)、计算机断层扫描 (CT)、超声和血管造影，主要用于多种癌症的临床治疗。 此外，由于不健康生活方式的增加和人口老龄化，一些国家的癌症发病率正在飙升，增加了对放射组学等新技术的接受度。 因此，老年人口的增加和癌症患者数量的增加将推动全球放射组学市场。

市场细分

全球放射组学市场可以根据模式、成像类型、技术、应用、地区和公司进行细分。 基于模式，市场分为磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等。 根据图像类型，市场分为 2D 和 3D。 基于技术，市场分为工程特征和深度学习。 根据应用，市场分为核医学、医学影像、精准医学、肿瘤学等。

公司简介

全球放射组学市场的主要参与者包括 Radiomics.io（计算成像和生物信息学实验室）、Radiomics Bio（比利时）、Health Innovation Ventures (HIV)、Sophia Genetics SA、HealthMyne Inc、Oncoradiomics 和 ptTheragnostic BV，以及其他的。

报告范围

本报告将全球放射组学市场分为以下几类，以及下面详述的行业趋势：

按模式划分的放射组学市场

  • 磁共振成像 (MRI)
  • 计算机断层扫描 (CT)
  • PET（正电子发射断层扫描）
  • 其他

放射组学市场，按图像类型：

  • 二维
  • 3D

放射组学市场，按技术

  • 工程功能
  • 深度学习

放射组学市场，按应用

  • 核医学
  • 医学成像
  • 精准医学
  • 肿瘤学
  • 其他

按地区划分的放射组学市场

  • 北美
    • 美国
    • 墨西哥
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 科威特

竞争格局

公司简介：对全球放射组学市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

  • 品牌知名度
  • 放射组学对各种治疗领域的影响
  • 引入放射组学的障碍

第5章临床试验分析

  • 正在进行的临床试验
  • 已完成临床试验
  • 已完成临床试验
  • 管道细分：按开发阶段
  • 管道细分：按状态
  • 渠道细分：按研究应用
  • 按地区划分的渠道细分
  • 临床试验热图

第六章专利分析

第7章全球放射组学市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按地区
    • 按公司分类（2022 年）
  • 产品市场地图
    • 按方式
    • 按图片类型
    • 按技术
    • 通过申请
    • 按地区

第八章北美放射组学市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 9 章：欧洲放射组学市场的前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 10 章亚太放射组学市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第11章南美放射组学市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 12 章中东和非洲放射组学市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按模式（磁共振成像 (MRI)、计算机断层扫描 (CT)、正电子发射断层扫描 (PET) 等）
    • 按图片类型（2D/3D）
    • 按技术（工程化功能与深度学习）
    • 按应用（核医学、医学成像、精准医学、肿瘤学等）
    • 按国家
  • MEA：国家分析
    • 南非 Radiomix
    • 沙特阿拉伯放射组学
    • 阿联酋 Radiomix
    • 科威特放射组学

第 13 章市场动态

  • 司机
    • 人工智能在医学影像诊断中的融合
    • 提高辐射在医学诊断中的可靠性
    • 患癌症和心血管疾病的人口增加
  • 做
    • 成像协议未标准化/技术限制
    • 关于医院预算削减
    • 缺乏验证和假阳性结果的风险

第十四章市场趋势与发展

  • 不断发展的研究和投资活动
  • 新兴国家的商机
  • 致力于引入更好的医疗保健设施

第15章竞争格局

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（As Reported）
  • Recent Developments
  • SWOT Analysis
    • Radiomics.io（Computational Imaging & Bioinformatics Lab）
    • Radiomics Bio（Belgium）
    • Health Innovation Ventures（HIV）
    • Sophia Genetics SA
    • HealthMyne Inc
    • Oncoradiomics
    • ptTheragnostic BV

第16章 战略建议

简介目录
Product Code: 7872

Global Radiomics Market is projected to grow at a formidable rate in the forecast period, 2018-2028. This can be attributed to the growing prevalence of various chronic diseases such as cancer which require accurate diagnosis and treatment. According to the global cancer observatory, the total number of new cancer cases reported in 2020 was around 19,292,789. Out of this, 10,065,305 new cancer cases were reported in males, and in females were around 9,227,484 in 2020. The rising need of improving disease diagnosis, prognosis, and clinical decision support is expected to create new prospects for the growth of global radiomics market.

Radiomics is a quantitative method of approaching medical imaging that seeks to improve the data already available to doctors through sophisticated mathematical analysis. Using analysis techniques from the field of artificial intelligence, radiomics evaluate textural information by mathematically extracting the spatial patterns of signal intensities and pixel interconnections. The potential of radiomics to improve clinical decision-making has been highlighted by numerous research from various imaging domains that have been published so far. The numerous technical parameters impacting the retrieved radiomic properties are the primary cause of the numerous significant hurdles the area is currently facing.

Increased Digitization and Use of Artificial Intelligence in the Healthcare Industry

The digitization of information, produced during normal clinical procedures has increased steadily in medicine over the past few decades, much like it has in many other spheres of human endeavor. As more medical records were made available in digital form, ever-evolving, and more complex software was created to analyze them. At the same time, research on artificial intelligence (AI) has long advanced to the point where its techniques and software tools are sophisticated enough to leave computer science departments and find use in an expanding number of fields. As a result, the medical industry has seen a significant rise in the use of AI applications in recent years. These apps are intended to help clinical decision-making and simplify the repetitive tasks that physicians must perform daily.

Radiomics enhances the available data to physicians with the help of modern mathematical analysis. The concept of radiomics has been most widely implied in the field of oncology basically on the assumption of the presence of certain disease-specific information not perceptible by the human eye in biomedical images.

Different modalities can aid in radiomics analysis on medical images, employing the potential additive value of imaging information retrieved from positron-emission-tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI), rather than assessing each modality on its own, thus permitting an integrated cross-modality approach. Therefore, the integration of AI into the healthcare industry will fuel the global radiomics market in the future.

Increased Dependency on Radiology for Medical Diagnosis

Medical Imaging procedures facilitate diagnosis and pave an approach for the treatment of adults as well as children and lately, there has been a remarkable rise in the use of these techniques.

Between October 2018 and September 2019, about 45.2 million imaging tests were carried out in England, according to a report by the National Health Service (NHS). Out of these, 3.58 million imaging tests were just conducted in September 2019.

This escalation can be attributed to increased demand by physicians and patients, technological improvements, and better financial conditions for people. Computed Tomography or CT scans have seen a rise of about 8% in the past ten years. It has been revealed by a survey that the rate of CT scans being conducted for respiratory diseases in the emergency department has increased by four folds between 2001 and 2010.

Technological advancements have led to more physicians calling for CT scans and MRIs even for conditions that could be investigated with simpler imaging techniques. An improved view of pathologies can be obtained from a CT scan than a plain radiograph. For example, the best imaging technique suitable for identification and follow-up on pulmonary embolism is CT pulmonary angiography. The chief reason for this is its fast speed and high resolution. CT scan has greater sensitivity and specificity along with enhanced visualization due to which it has the potential to identify small opacities that might have been skipped during chest X-rays. Also, it can offer improved views of some regions such as lung lingula and lung bases. This increased dependency on radiology for medical diagnosis is offering lucrative growth opportunities for the global radiomics market.

Growing Geriatric Population and Associated Diseases

With advancing age, the risk of contracting a disease also increases. Nearly 80% of elderly people in the United States have at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC). Furthermore, it has been estimated by the American Medical Association (AMA) that about 60% of individuals with an age of 65 or above will be living with more than one chronic condition by the year 2030. Therefore, the rise in the geriatric population in the world will fuel the necessity for better healthcare facilities and modern treatment options as well as medications.

The increased incidences of chronic diseases worldwide will drive the demand for modern diagnostic and treatment options. Radiology techniques or medical imaging procedures such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, ultrasound, and angiography are principally deployed for clinical procedures carried out for several cancers. Also, with a rise in unhealthy lifestyle habits and a rising elderly population, the incidence of cancer is on a surge across several countries, thereby raising the acceptance of novel technologies like radiomics. Hence, the growing geriatric population along with rising cancer cases will propel the global radiomics market.

Market Segmentation

Global radiomics market can be segmented based on modality, image type, technology, application, region, and company. Based on modality, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron-emission tomography (PET), and others. Based on image type, the market is split into 2D and 3D. Based on technology, the market is divided into engineered features and deep learning. Based on application, the market is fragmented into nuclear medicine, medical imaging, precision medicine, oncology, and others.

Company Profiles

Some of the leading players operating in the global radiomics market are Radiomics.io (Computational Imaging & Bioinformatics Lab), Radiomics Bio (Belgium), Health Innovation Ventures (HIV), Sophia Genetics SA, HealthMyne Inc, Oncoradiomics, and ptTheragnostic BV, among others.

Report Scope:

In this report, global radiomics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiomics Market, By Modality:

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron-Emission-Tomography (PET)
  • Others

Radiomics Market, By Image Type:

  • 2D
  • 3D

Radiomics Market, By Technology:

  • Engineered Features
  • Deep Learning

Radiomics Market, By Application:

  • Nuclear Medicine
  • Medical Imaging
  • Precision Medicine
  • Oncology
  • Others

Radiomics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global radiomics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

  • 4.1. Brand Awareness
  • 4.2. Impact of Radiomics on Different Therapeutic Areas
  • 4.3. Barriers to Adoption of Radiomics

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Patents Analysis

7. Global Radiomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 7.2.2. By Image Type (2D v/s 3D)
    • 7.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 7.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 7.2.5. By Region
    • 7.2.6. By Company (2022)
  • 7.3. Product Market Map
    • 7.3.1. By Modality
    • 7.3.2. By Image Type
    • 7.3.3. By Technology
    • 7.3.4. By Application
    • 7.3.5. By Region

8. North America Radiomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 8.2.2. By Image Type (2D v/s 3D)
    • 8.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 8.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Radiomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Modality
        • 8.3.1.2.2. By Image Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
    • 8.3.2. Mexico Radiomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Modality
        • 8.3.2.2.2. By Image Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
    • 8.3.3. Canada Radiomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Modality
        • 8.3.3.2.2. By Image Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application

9. Europe Radiomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 9.2.2. By Image Type (2D v/s 3D)
    • 9.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 9.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 9.2.5. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Radiomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Modality
        • 9.3.1.2.2. By Image Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
    • 9.3.2. Germany Radiomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Modality
        • 9.3.2.2.2. By Image Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
    • 9.3.3. United Kingdom Radiomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Modality
        • 9.3.3.2.2. By Image Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
    • 9.3.4. Italy Radiomics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Modality
        • 9.3.4.2.2. By Image Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
    • 9.3.5. Spain Radiomics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Modality
        • 9.3.5.2.2. By Image Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application

10. Asia-Pacific Radiomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 10.2.2. By Image Type (2D v/s 3D)
    • 10.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 10.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 10.2.5. By Country
  • 10.3. Asia-Pacific: Country Analysis
    • 10.3.1. China Radiomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Modality
        • 10.3.1.2.2. By Image Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
    • 10.3.2. India Radiomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Modality
        • 10.3.2.2.2. By Image Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
    • 10.3.3. Japan Radiomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Modality
        • 10.3.3.2.2. By Image Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
    • 10.3.4. South Korea Radiomics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Modality
        • 10.3.4.2.2. By Image Type
        • 10.3.4.2.3. By Technology
        • 10.3.4.2.4. By Application
    • 10.3.5. Australia Radiomics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Modality
        • 10.3.5.2.2. By Image Type
        • 10.3.5.2.3. By Technology
        • 10.3.5.2.4. By Application

11. South America Radiomics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 11.2.2. By Image Type (2D v/s 3D)
    • 11.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 11.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 11.2.5. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Radiomics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Modality
        • 11.3.1.2.2. By Image Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
    • 11.3.2. Argentina Radiomics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Modality
        • 11.3.2.2.2. By Image Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
    • 11.3.3. Colombia Radiomics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Modality
        • 11.3.3.2.2. By Image Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application

12. Middle East and Africa Radiomics Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
    • 12.2.2. By Image Type (2D v/s 3D)
    • 12.2.3. By Technology (Engineered Features v/s Deep Learning)
    • 12.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
    • 12.2.5. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Radiomics Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Modality
        • 12.3.1.2.2. By Image Type
        • 12.3.1.2.3. By Technology
        • 12.3.1.2.4. By Application
    • 12.3.2. Saudi Arabia Radiomics Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Modality
        • 12.3.2.2.2. By Image Type
        • 12.3.2.2.3. By Technology
        • 12.3.2.2.4. By Application
    • 12.3.3. UAE Radiomics Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Modality
        • 12.3.3.2.2. By Image Type
        • 12.3.3.2.3. By Technology
        • 12.3.3.2.4. By Application
    • 12.3.4. Kuwait Radiomics Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Modality
        • 12.3.4.2.2. By Image Type
        • 12.3.4.2.3. By Technology
        • 12.3.4.2.4. By Application

13. Market Dynamics

  • 13.1. Drivers
    • 13.1.1. Integration of Artificial Intelligence in Medical Imaging
    • 13.1.2. Increased Reliance Radiology for Medical Diagnosis
    • 13.1.3. Growing Population with Cancer and Cardiovascular Disorders
  • 13.2. Challenges
    • 13.2.1. Imaging Protocols Not Standardized/Technological Restraints
    • 13.2.2. Budget Cuts of Hospitals
    • 13.2.3. Lack of Validation and Risk of False-Positive Results

14. Market Trends & Developments

  • 14.1. Growing Research and Investment Activities
  • 14.2. Opportunities in Emerging Countries
  • 14.3. Adoption of Better Healthcare Facilities

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (As Reported)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Radiomics.io (Computational Imaging & Bioinformatics Lab)
    • 15.6.2. Radiomics Bio (Belgium)
    • 15.6.3. Health Innovation Ventures (HIV)
    • 15.6.4. Sophia Genetics SA
    • 15.6.5. HealthMyne Inc
    • 15.6.6. Oncoradiomics
    • 15.6.7. ptTheragnostic BV

16. Strategic Recommendations